Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR
Ablative case
DOI:
10.1016/j.ijrobp.2024.11.084
Publication Date:
2024-11-28T17:18:12Z
AUTHORS (34)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....